1. Home
  2. GNLX vs HYNE Comparison

GNLX vs HYNE Comparison

Compare GNLX & HYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.88

Market Cap

113.6M

Sector

Health Care

ML Signal

HOLD

HYNE

Hoyne Bancorp Inc.

N/A

Current Price

$15.68

Market Cap

116.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GNLX
HYNE
Founded
2001
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
113.6M
116.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
GNLX
HYNE
Price
$2.88
$15.68
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$17.25
N/A
AVG Volume (30 Days)
152.2K
14.9K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
9.47
N/A
EPS
N/A
N/A
Revenue
$8,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.29
$13.56
52 Week High
$8.54
$16.14

Technical Indicators

Market Signals
Indicator
GNLX
HYNE
Relative Strength Index (RSI) 55.87 53.69
Support Level $2.36 $15.49
Resistance Level $2.97 N/A
Average True Range (ATR) 0.19 0.23
MACD 0.04 -0.06
Stochastic Oscillator 52.64 31.37

Price Performance

Historical Comparison
GNLX
HYNE

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About HYNE Hoyne Bancorp Inc.

Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.

Share on Social Networks: